Difference in allelic expression of genes probably associated with tumor progression in murine fibrosarcomas and cell lines
- PMID: 7961103
- PMCID: PMC5919358
- DOI: 10.1111/j.1349-7006.1994.tb02899.x
Difference in allelic expression of genes probably associated with tumor progression in murine fibrosarcomas and cell lines
Abstract
Allelic expression was examined by single-strand conformation polymorphism analysis in murine fibrosarcomas from inter-subspecific F1 mice between C57BL/6 and MSM. Ten genes encoding p53, mdm2, E-cadherin, 72 kD metalloproteinase and its inhibitor (Timp2), thymidine kinase and four glucose transporters (Gluts) were examined. These genes were chosen because of their probable association with tumor development and progression. In some of the tumors and cell lines, p53, E-cadherin and Glut3 genes showed remarkable differences in allelic expression, one allele being poorly expressed. The allele-specificity persisted in nine cell lines obtained by repeated transplantations from one tumor. These results suggest that expression of some genes is allele-specific in tumor cells and the pattern of specificity is stable. Such a decrease or a loss of expression in one of the alleles may be functionally equivalent to the loss of heterozygosity of the gene, and therefore this may confer malignant properties on tumor cells. It is also suggested that differential expression of two alleles is a common event in tumor cells.
Similar articles
-
A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.J Exp Clin Cancer Res. 1999 Sep;18(3):403-16. J Exp Clin Cancer Res. 1999. PMID: 10606188
-
p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters.Mol Carcinog. 1995 Aug;13(4):266-71. doi: 10.1002/mc.2940130409. Mol Carcinog. 1995. PMID: 7646765
-
Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.Cancer. 1997 Feb 15;79(4):700-16. Cancer. 1997. PMID: 9024708
-
The mdm2 proto-oncogene.Leuk Lymphoma. 1997 Jul;26(3-4):227-38. doi: 10.3109/10428199709051772. Leuk Lymphoma. 1997. PMID: 9322885 Review.
-
Osteosarcoma in blood relatives.Oncol Rep. 2001 Jan-Feb;8(1):131-6. doi: 10.3892/or.8.1.131. Oncol Rep. 2001. PMID: 11115584 Review.
Cited by
-
Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues.Jpn J Cancer Res. 1997 Aug;88(8):732-7. doi: 10.1111/j.1349-7006.1997.tb00444.x. Jpn J Cancer Res. 1997. PMID: 9330604 Free PMC article.
References
-
- ) Han , K. A. and Kulesz‐Martin , M. F.Altered expression of wild‐type p53 tumor suppressor gene during murine epithelial cell transformation . Cancer Res. , 52 , 749 – 753 ( 1992. ). - PubMed
-
- ) Klein , G.The approaching era of the tumor suppressor genes . Science , 238 , 1539 – 1545 ( 1987. ). - PubMed
-
- ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 53 ( 1991. ). - PubMed
-
- ) Vogelstein , B. and Kinzler , K. W.p53 function and dysfunction . Cell , 70 , 523 – 526 ( 1992. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous